Articles

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Sadanand Maurya*¹, Devendra Goyal², Chandan Verma^1
1 Department of Quality Assurance in Macleods Pharmaceutical Limited
² Department of Production in Macleods Pharmaceutical Limited
*sadanandmpharma@gmail.com

ABSTRACT
Manufacturing of Pharmaceutical products shall demonstrate a control to reproduce consistently the desired quality of product, wherein the control of cross-contamination plays an important role. An effective cleaning shall be in place to provide documented evidence that the cleaning methods employed within a facility consistently controls potential carryover of product (including intermediates and impurities), cleaning agents and extraneous material into subsequent product to a level which is below predetermined levels. Pharmaceutical manufacturers must validate their cleaning process to ensure compliance with cGMP regulations. So it is necessary to validate the cleaning procedures to ensure safety, efficacy, quality of the subsequent batches of drug product and regulatory requirements in Pharmaceutical product manufacture. In this article cleaning validation and cleaning validation program discussed in brief.

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
G.Hema Latha¹*, MD.Sultan Ali², C.Vijaya lakshmi  R.Kiran kumar¹, C.V.H.Hemavathy^1
1 Kottam Institute of Pharmacy, Erravally X Roads, Mahaboob Nagar, Telangana
² Safa College of Pharmacy, Kurnool, A.P
*hemarayudu19@gmail.com

ABSTRACT
Protective effect of ziziphus jujuba  in cerebral ischemia reperfusion injury in albino rats. The main aim of the present work is to evaluate the Protective effect of Ziziphus jujuba  in cerebral ischemia reperfusion injury in albino rats. Objectives are to test the  Preliminary phytochemical screening of Aqueous & Petroleum ether extracts of “Ziziphus Jujuba”. Group 1: Control group; Group 2: Animals treated with lead 0.1 ml/100 g body weight i.p; Group 3: Animals treated with Petroleum ether extract of Ziziphus Jujuba 250mg/kg; Group 4: Animals treated with Petroleum ether extract of Ziziphus Jujuba 500mg/kg.All the groups were subjected to pre-treatment for a period of 7 days except Control group. To compare the changes in Quantification of infract size in normal and treated groups. To compare the changes in SGOT levels in Control and treated groups. The protective effect of the aqueous extract ,petroleum ether extract of Ziziphus Jujuba may be due to the presence of flavonoids, saponins, triterpenoids and tannins. There was a dose dependent increase in cerebral protection in terms of reduction of infarct size of brain tissue and SGOT levels in serum. Furthermore investigation is needed to find out the particular constituent which is responsible this protective activity.

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
S. Ashutosh Kumar*, Manidipa Debnath,Vaddi Pavan Krishna Kumar
Department of Pharmaceutical Analysis and Quality Assurance,
A.K.R.G College of Pharmacy,
Nallajerla, West Godavari, A.P
* ashu.mpharm2007@gmail.com

ABSTRACT
Purpose: A simple, precise, accurate, rapid and economical reverse phase high-pressure liquid chromatographic method has been developed as per ICH norms for the estimation of Naproxen from pharmaceutical formulation.
Methods: The method was carried out on a Kromosil-C₁₈ ODS column (150 mm X 4.6 mm; 5 µ) with a mobile phase consists of ammonium acetate buffer (adjusted to pH 4.0 with 1 % Triethyl amine): methanol (40:60 v/v) and filtered through a 0.45 µ cellulose nitrate filters. The flow rate was maintained in isocratic mode at 1.0 mL/min. The detection was carried out at 210 nm. The run time was 7.0 min.
Results: The retention time was 3.063 min for Naproxen. The developed method was validated in terms of accuracy, precision, linearity, limit of detection, limit of quantification and solution stability.
Conclusion: The proposed method was adequate sensitive, reproducible, and specific for the determination of Naproxen in bulk as well as in tablet dosage forms.

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Abdul Waheed*, Swati Pathak, Roohi Mirza
Department of Pharmacology,
Amity Institute of Pharmacy,
Amity University, Noida, U.P., India
*abdul.waheed2050@gmail.com

ABSTRACT
Epilepsy is a chronic brain disorder characterized by tendency to recurrent seizures or fits. The seizures can leads to loss of consciousness, disturbance of movement, muscle spasms, autonomic and mental functions. Epilepsy is developed because of imbalance in nerve signalling chemical called neurotransmitters. During epilepsy, the level of excitatory neurotransmitter glutamate increases and the level of inhibitory neurotransmitter GABA decrease. These lead to abnormal signalling in brain causes epilepsy. Primary diagnosis of epilepsy includes eye–witness and family history. Electroencephalograph (EEG) is the cornerstone for diagnosis of epilepsy and measures the brain wave activity. Neuroimaging like computed tomography (CT) scan, magnetic resonance imaging (MRI) and positron emission tomography (PET) techniques are used to diagnose abnormalities in structure and function of brain. Video recording is also useful for the monitoring of epileptic events. The most common approach of treatment is to prescribe antiepileptic drugs (AEDs). Three generations of AEDs including phenytoin, valproate, carbamazapine, lamotrigine, Oxcarbazepine, Primidone,Phenobarbitone,Gabapentin, Topiramate, Levetiracetam, Felbamate, Rufinamide, Zonisamide, Tiagabinand Vigabatrin etc. are prescribed. These AEDs have some teratogenic effects on  pragnent woman and lactating mother; need precautions. Instead of  pharmacological approaches, Non-pharmacological approaches also used for the treatment of epileptic seizures like ketogenic diet, atkins diet, yoga etc. Thr purpose of this review is to update the current knowledge on epilepsy classification, diagnostics, approaches of treatment, pathophysiology, mechanism of epileptogenesis and teratogenic effects.